[pegleg]

Good news from the Spheramine sponsor:
SOUTH SAN FRANCISCO, Calif., July 26 /PRNewswire-FirstCall/ -- Titan Pharmaceuticals, Inc. (OTC Bulletin Board: TTNP) today announced that the National Institutes of Health (NIH) has awarded the company a grant under the Small Business Innovation Research (SBIR) program supporting the development of a long-term, non-fluctuating dopamine agonist treatment for Parkinson's disease. The first year award in the amount of $300,000 will be available to Titan starting August 1, 2010, and an additional $195,000 for the second year starting August 1, 2011 has been recommended subject to availability of funds and satisfactory progress of the project. The grant will be administered by the National Institute of Neurological Disorders and Stroke (NINDS).
* * *
Titan's ProNeura technology can be used to develop a subcutaneous implant that provides round-the-clock delivery of dopamine agonists while maintaining a stable, non-fluctuating plasma drug level for 6 months or longer following a single treatment. The SBIR grant will cover all the external expenses for the initial evaluation of the non-clinical safety and efficacy of implant formulations of select dopamine agonists that are currently marketed for the treatment of PD. These studies will take approximately two years to complete and the data will provide a basis for further development of potential product candidates that may alleviate the 'on/off' motor fluctuations and treatment-related dyskinesias associated with current dopamine-replacement treatment regimens.
http://www.prnewswire.com/news-relea...-99260149.html
"